Regional control of tumor growth

Molecular Cancer Research

Volumn 8, Issue 9, 2010, Pages 1198-1206

  Zaslavsky, Alexander ^a,b   Chen, Catherine ^a   Grillo, Jenny ^a   Baek, Kwan Hyuck ^a,b   Holmgren, Lars ^d   Yoon, Sam S ^c   Folkman, Judah ^a   Ryeom, Sandra ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 1;

ABDOMEN; ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CANCER GRAFT; CANCER GROWTH; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENTERY; METASTASIS; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ABDOMEN; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICROVESSELS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; PERITONEAL CAVITY; PERITONEUM; THROMBOSPONDIN 1; TUMOR MICROENVIRONMENT;

MUS;

EID: 77957160710     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0047     Document Type: Article

References (26)

1. Twort J, Twort CC. The variable sensitivity of different sites of the skin of mice to carcinogenic agents. J Pathol Bacteriol 1936;42:303-16.
2. Kobayashi K. Regional differences in mitotic activity due to injury in mouse skin. Cell Tissue Res 1976;175:319-24.
3. Sugarbaker PH. Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol 2007;95:93-6.
4. Sano T. Is peritoneal carcinomatosis an incurable disease or controllable locoregional condition? - Challenge of surgeons with intraperitoneal hyperthermic chemotherapy. Jpn J Clin Oncol 2001;31:571-2.
5. Jacquet P, Vidal-Jove J, Zhu B, Sugarbaker P. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. Acta Chir Belg 1994;94:191-7.
6. Sethena S. New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative intraperitoneal chemotherapy. Cancer Ther 2004;2:79-84.
7. Sugarbaker PH. Review of a personal experience in themanagement of carcinomatosis and sarcomatosis. Jpn J Clin Oncol 2001;31:573-83.
8. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev 2007;6:273-86.
9. Folkman J. Is angiogenesis an organizing principle in biology and medicine? J Pediatr Surg 2007;42:1-11.
10. Zhang X, Xu J, Lawler J, Terwilliger E, Parangi S. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Clin Cancer Res 2007;13:3968-76. (Pubitemid 47037605)
11. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 2002;6:1-12.
12. 3 integrin. Cancer cell 2003;3:589-601.
13. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989;56:345-55.
14. Fernando NT, Koch M, Rothrock C, et al. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by upregulation of multiple proangiogenic factors. Clin Cancer Res 2008;14:1529-39.
15. Lawler J, Sunday M, Thibert V, et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998;101:982-92.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods (San Diego, Calif) 2001;25:402-8.
17. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 2003;22:465-72.
18. Pilati P, Mocellin S, Rossi CR, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003;10:508-13. (Pubitemid 40486913)
19. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
20. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001;86:23-33.
21. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967-74.
22. Shojaei F, Ferrara N. Antiangiogenic therapy for cancer: an update. Cancer J 2007;13:345-8.
23. Folkman J. Endogenous angiogenesis inhibitors. APMIS 2004;112:496-507.
24. Kazerounian S, Yee KO, Lawler J. Thrombospondins in cancer. Cell Mol Life Sci 2008;65:700-12.
25. Bijelic L, Yan TD, Sugarbaker PH. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol 2008;98:295-9.
26. Sugarbaker PH. Building on a consensus. J Surg Oncol 2008;98:215-6.